Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TripleNine Group is a leading global producer of fish meal and fish oil, headquartered in Denmark. The company specializes in the processing of marine raw materials into high-quality ingredients for the aquaculture, agriculture, and human nutrition industries. Their product portfolio includes specialized Omega-3 oils used in the production of health supplements and pharmaceutical-grade fatty acids. TripleNine operates several production facilities across Europe and South America, maintaining a strong focus on sustainability and traceability in the marine supply chain. The company provides essential components for the life sciences sector, particularly in the development of lipid-based therapies and nutritional products. Through advanced refining and distillation processes, they ensure high purity levels of eicosapentaenoic acid and docosahexaenoic acid.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TripleNine Group.